Rome Therapeutics
Illuminating the dark genome to cure disease
Rome Therapeutics was founded in 2020, is headquartered in Boston, United States, lists 11–50 employees, and has $199.0M in recorded funding across 3 rounds.
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- rometx.com
- Total Funding
- $199.0M
- Last Round
- $72.0M Series BJun 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 12 investors for this company. The full record is or through the API.
About
ROME Therapeutics is a biotechnology company developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome—vast stretches of the genome previously considered non-functional 'dark genome' DNA. Launched in April 2020 and incubated by GV in collaboration with ARCH Venture Partners and Partners Innovation Fund, ROME has built a deep pipeline of drug candidates targeting transposable elements and other repeatome-derived biology. The company's platform combines genomics, data science, and drug discovery to identify new therapeutic targets invisible to conventional approaches. ROME has raised over $149 million through Series A and B financings, with investors including Andreessen Horowitz, Johnson & Johnson Innovation, and Bristol-Myers Squibb.
Summary
Rome Therapeutics is a Healthcare company based in Boston, United States, founded in 2020. It lists 11–50 employees. It has raised $199.0M in total across 3 rounds, most recently a $72.0M Series B round in Jun 2023. Investors include Johnson & Johnson Innovation, Mirae Asset and GV.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2023
Sign up to see all 3 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rome-therapeutics"><img src="https://indexed.vc/api/badge/company/rome-therapeutics" alt="Rome Therapeutics on Indexed.vc" width="260" height="76" /></a>